Article History
Received: 21 December 2016
Accepted: 23 January 2017
First Online: 1 April 2017
Competing interests
: J.J.O. and the National Institutes of Health hold patents related to Jaks as targets of immunomodulatory agents and have a Collaborative Research Agreement and Development Award with Pfizer.